Follow our teams research
-
FeaturedSPAC CIIG closes in on Merger with EV innovator Arrival
CIIG Merger Corp (NASDAQ: CIIC) first announced the reverse merger with Arrival in November 2020. The SPAC company CIIG Merger Corp has since gained over 108% in the share price, illustrating a bullish investor sentiment. Arrival Ltd. has peaked the interests of investors, with its evolutionary EV passenger bus and van models. Furthermore, the interest… Read more
-
FeaturedPlug Power stock forecast for 2022 – what do investors need to know?
Plug Power (NASDAQ:PLUG) stock has continued its bullish run, posting an impressive 1,102% increase over the past year. The hydrogen cell developer has kept analysts busy, toppling their 12 month price target expectations. Plug Power’s sheer operating scale makes it the largest liquid hydrogen consumer in the world. The stock has been strongly influenced by… Read more
-
FeaturedJoby Aviation to merge with SPAC Reinvent Technology (RTP) – here’s everything you need to know
Reinvent Technology Partners (NYSE: RTP) announced its intentions to take Joby Aviation public via a reverse merger. This announcement made waves on Wallstreet this week as Joby Aviation plans to launch its Air Taxi service in 2024. The aviation company will list on the NYSE however the new stock ticker is yet to be released. The… Read more
-
FeaturedLi Auto stock forecast for 2022 – smart money is bullish
The new age Chinese Electric Vehicle trio NIO, Xpeng and Li Auto have made their presence felt in the US markets. Li Auto Inc. (NASDAQ: LI) debuted on Wallstreet less than 7 months ago and has since seen an incredible surge in investor cofindence. The stock has gained 75% since its listing on the NASDAQ.… Read more
-
FeaturedCCIV announces merger with Lucid Motors – here’s what you need to know
Churchill Capital Corp IV (NYSE: CCIV) stock surged 214% over the past month as rumours on Wallstreet speculated the potential merger with Lucid Motors. On Monday afternoon CCIV officially announced its intentions to take Lucid Motors public in a reverse merger. Lucid Motors has made a name for itself on Wallstreet announcing its ambitions to… Read more
-
FeaturedTesla stock forecast for 2022 and beyond
Tesla stock (NASDAQ: TSLA) has continued its stellar run this year as the tech innovator continues to dominate the growing EV industry. Tesla’s stock price has risen 344% in the past year, its best performing trading period since its initial listing on Wallstreet. With such positive stock growth over the past year, investors are now… Read more
-
FeaturedFisker stock forecast for 2022 – analysts confident in EV prospect
Fisker (NYSE:FSR) has seen a positive month of trading, gaining over 20%. Fisker initially peaked investor interests early last year, after the company announced its intentions to merge with Spartan Energy Acquisition (SPAQ). In addition, the merger was one of the most talked about SPAC propositions in 2020. Fisker Inc. engages in the production of… Read more
-
FeaturedCAPA to merge with Quantum-si – here’s what you need to know
HighCape Capital Acquisition Corp (NASDAQ: CAPA) announced yesterday their intentions to merge with Quantum-Si, a leader in Semiconductor Chip-Based Proteomics. Simply put, Quantum-Si have developed a semiconductor chip that potentially has the power to decode the molecules of life. Furthermore, this holds the “potential to advance drug discovery and ultimately diagnostics beyond what has been possible with… Read more
-
FeaturedNIO stock forecast for 2022 and beyond
Nio Inc – (NYSE: NIO) has had a stellar year of trading, outperforming investor and analyst expectations. NIO stock has gained 334% over the past 6 months of trading, cementing its name as one of 2020’s best performing stocks. In addition, the Chinese EV manufacturer managed to deliver over 12,000 vehicles in the third quarter… Read more
-
FeaturedACIC to merge with Archer – here’s what you need to know
Atlas Crest Investment Corp (NYSE: ACIC) announced its intention to merge with Urban Air Mobility company Archer. The news of the merger sent ACIC stock surging over 20% to a 52 week high of $15.75. The SPAC merger is expected to provide the merged company $1.1 billion of gross proceeds to fund future growth. This article… Read more
-
FeaturedSundial Growers (SNDL) stock forecast for 2022
Sundial Growers Inc (NASDAQ: SNDL) has surged 439% over the past month of trading. Other industry competitors Tilray (NASDAQ: TLRY) and Aurora Cannabis (TSE: ACB) have also seen impressive gains after a shift in sentiment on Wallstreet. SNDL’s strong stock performance is attributed to optimism surrounding possible changes in legalisation of cannabis in the United… Read more
-
FeaturedFuelCell stock forecast for 2022 and beyond
FuelCell Energy (NASDAQ: FCEL) has seen an incredible amount of growth on Wallstreet this year alone. The stock has gained 63% in the past month of trading. FCEL, alongside its competitor PLUG Power have gained investor confidence partly due to the congressional passage of an alternative fuels tax credit through the Biden administration bent towards renewable energy. However, analysts… Read more
-
FeaturedFord Motor stock forecast for 2021
Ford Motor Company (NYSE: F) is providing a glimmer of hope as we open the door to 2021. Bulls, in particular analysts, are confident Ford stock will continue to gain in 2021. However, the bears are not backing down as they expose the gapping debt holes in the business. This article will look to provide… Read more
-
FeaturedGM stock forecast for 2022 – are analysts bullish?
General Motors Company (NYSE: GM) has had an impeccable year of trading. Long term shareholders have been rewarded as the company has gained serious ground on Wallstreet. General Motors stock has gained 58% YTD, marking one of its best performing years since IPO. In addition, the analysts on Wallstreet are rallying behind the vehicle manufactuer.… Read more
-
FeaturedPalantir stock forecast for 2022- are analysts bullish?
Palantir Technologies (NYSE: PLTR) has seen an incredible debut on Wallstreet. The stock has climbed 279% over the past month, far exceeding analysts expectations. Palantir specialises in big data analytics, in particular within the realm of law enforcement and surveillance. Palantir recently announced its partnership with tech giant IBM on artificial-intelligence applications. This is off… Read more
-
FeaturedBNGO stock forecast for 2021 and beyond
BioNano Genomics Inc (NASDAQ: BNGO) has had a remarkable year of trading, gaining over 979% over the past two months. The company operates in the analytical instruments field, in particular cytogenomics. Simply put, this is the detection of genetic disorders by analyzing the variances in chromosomes. BioNano have developed the Saphyr platform, which has been a… Read more
-
FeaturedIPOE closes in on SoFi merger – what you need to know
Social Capital Hedosophia Holdings V Corp (NYSE: IPOE) is peaking interest amongst investors as it closes in on its merger with finance giant SoFi. The merger marks just one of the six SPAC ventures owner Chamath Palihapitiya is pursuing in 2021. The merger news was first announced in early January, driving the stock price up… Read more
-
FeaturedXL Fleet stock forecast – will it hit $30?
XL Fleet Corp (NYSE: XL) has closed out its first official month trading on Wallstreet, after completion of the SPAC merger with PIC. The stock is down 6% in the past 30 days, with XL Fleet investors experiencing a rollercoaster of volatility. The stock peaked at $35 a share in late December however analysts are… Read more
-
FeaturedVXRT stock surges 116% – analysts maintain buy rating
Vaxart Inc (NASDAQ: VXRT) has seen a remarkable year on Wallstreet after investors rallied behind its experimental COVID-19 vaccine. VXRT stock has gained some serious ground over the past year, surging over 1,559% YTD. Unlike other COVID-19 vaccine candidates, the vaccine is administered orally and can be stored at room temperature. Analysts are certainly bullish… Read more
-
FeaturedWorkhorse stock forecast for 2022 and beyond
Workhorse Group Inc (NASDAQ: WKHS) posted an impressive week of trading, gaining over 45%. The company designs and builds performance battery-electric vehicles and aircraft, along with cloud based, real-time telematics performance monitoring systems. Investors have rallied around the Ohio EV manufacturer, with a game changing $8.1 Billion contract from USPS on the horizon. Furthermore, with… Read more
-
FeaturedAnalysts maintain buy rating on SRNE stock
Sorrento Therapeutics Inc (NASDAQ: SRNE) has recaptured the attention of investors as analysts remain confident in the companies 12 month outlook. The stock has performed well as of late, posting a 29% gain over the past month of trading. Furthermore, the average 12 month price target amongst Wallstreet analysts is $29.67 a share. This suggests… Read more
-
FeaturedGameStop stock surges 263% – here’s what analysts are saying
GameStop Corp. (NYSE: GME) has baffled investors on Wallstreet after it surged well over 93% in the last week of trading. GME remains extremely volatile, reaching a 52 week high of $159.18 before plummeting back down to $70 a share. Investors have crunched GME’s daily volume, with 197.2 million shares exchanged compared to the daily… Read more
-
FeaturedHere’s what you need to know about the GHIV merger
Gores Holdings IV Inc (NASDAQ: GHIV) is set to close in on its merger with United Wholesale Mortgage. The merger marks an exciting new chapter for the mortgage lender, as it will list on the NASDAQ under the ticker UWMC. Shareholders of Gores Holding stock voted yesterday to seal the merger, which is the final… Read more
-
FeaturedAre analysts now bullish on FuboTV stock?
FuboTv Inc (NYSE: FUBO) created ripples on Wallstreet last week after the company announced its plan to acquire sports betting and interactive gaming company Vigtory. The news sent the stock surging 20% higher with hopes the company will launch its sport book by the end of the fiscal year. In addition, the shift in analyst… Read more
-
FeaturedWill Quantumscape bounce back in 2021?
Quantumscape Corp (NYSE: QS) has entered headlines on Wallstreet over the past three weeks after the stock tumbled 57%. The stock went into free fall over the New Year period before finding a new equilibrium at $56.79 a share. Following the sharp decline, CEO Jagdeep Singh affirmed his confidence that the volatility was related solely… Read more
-
FeaturedWill Romeo Power stock thrive in 2021?
Romeo Power (NYSE:RMO) has been in the spotlight this week after its timely debut on Wallstreet. The company officially began trading on the 30th of December 2020, following the completion of its reverse merger with RMG Acquisition Corp. The companies first days of trading saw a decline of 35%, after PIPE investors and speculators capitalised… Read more
-
FeaturedIPOC closes in on merger with Clover Health – now what?
Social Capital Hedosophia (NYSE: IPOC) are set to close in on their merger with Clover Health in early 2021. Evidently, this has caused a strong upswing in investor momentum in IPOC’s trading price. IPOC has gained 33% over the past week of trading and 66% for the month of December. The Special Purpose Acquisition Company… Read more
-
FeaturedRoku stock forecast for 2021 – here’s what analysts are saying
Roku Inc (NASDAQ: ROKU) has seen a remarkable gain in investor confidence in 2020. Evidently, the Roku stock price has surged over 162% in the past six months of trading. The companies stock hit all time highs late last week after they announced their deal with AT&T’s HBO Max. The strong momentum can also be… Read more
-
FeaturedBreaking down AT&T’s stock forecast for 2021
AT&T Inc. (NYSE: T) has gripped investor interest on Wallstreet as the company took a heavy hit due to COVID earlier this year. Founded in 1983, AT&T is a US-based telecoms company. AT&T is the second largest provider of mobile services and the largest provider of fixed telephone services in the US. The telecoms giant turned… Read more
-
FeaturedNVDA stock forecast for 2021 – the bulls take charge
NVIDIA Corporation (NASDAQ: NVDA) has provided investors a golden opportunity in 2020 for steady growth. The companies share price has gained 132% in value in 2020 alone. The tech giant manufactures Graphic Processing Units (GPU) for Gaming and specialised markets. With such positive growth, analysts have weighed in and the 12 month outlook may surprise… Read more
-
FeaturedPIC closes in on XL fleet merger – here’s what you need to know
Pivotal Investment Corporation II (NYSE: PIC) announced on Tuesday they will be holding an annual meeting on December 21 for shareholders to vote on the proposed merger with XL Fleet. The shareholder vote is one of the last steps in the lengthy merger process. In addition, both companies will merge under the one ticker, NYSE:XL. PIC… Read more
-
FeaturedNorthern Genesis stock surges on merger with EV innovator
Northern Genesis Acquisition Corp (NYSE: NGA) announced last week they have entered an agreement to merge with EV manufacturer Lion Electric. The merger adds to the vastly growing list of EV innovators jumping on board the SPAC train to raise much needed capital. The NGA merger is to be completed in the first quarter of… Read more
-
FeaturedModerna and Novavax surge ahead of 2021 – here’s what you need to know
The past two weeks have seen a large shift in investor sentiment towards these two key COVID vaccine pioneers. Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) have seen a recent surge in the share price. The companies saw an increase of 26.52% (NVAX) and 38.26% (MRNA) respectively over the past week of trading.… Read more
-
FeaturedWhat the Salesforce Slack acquisition means for investors
Salesforce.com, inc. (NYSE: CRM) announced yesterday the acquisition of Slack Technologies (NYSE: WORK). Since rumours first broke of the announcement of the acquisition, Slack shares bounced from $29 to $40 a share. The definitive agreement marks an estimated enterprise value of $27.7 billion based upon Salesforce’s current trading price. The transaction is expected close in… Read more
-
FeaturedHennessy Capital surges 34% on merger – here’s what you need to know
Hennessy Capital Acquisition Corp IV Class A (NASDAQ: HCAC) has recently gained a fresh vote of confidence from investors. The Special Purpose Acquisition Company (SPAC) has seen an impressive gain of 34% in the share price over the past month. On August 18th, the company announced it had reached a definitive agreement with Canoo, a… Read more
-
FeaturedBank of America turns bullish on NIO stock
Nio Inc – (NYSE: NIO) has continued to outperform analysts expectations this year as the Chinese EV continues to deliver strong revenue growth. The companies stock price has seen a remarkable gain of 2,500% over the past year. The trading activity has seen a spike in recent days after the Q3 earnings announcement alongside the… Read more
-
FeaturedXpeng stock surges after key analyst upgrade
Xpeng Inc – ADR (NYSE: XPEV) has surpassed all expectations on Wallstreet after multiple upgrades from large institutions. The company has seen a 92% gain over the past month, outperforming its Chinese counterparts NIO and Li Auto. Xpengs unique technology and innovative EV performance has positively shifted investor sentiment. Yesterday afternoon, Citigroup analyst Jeff Chung… Read more
-
FeaturedPalantir stock turns bullish – do analysts suggest a buy rating?
Palantir Technologies (NYSE: PLTR) has surged by 16% on Friday as investors continue to rally behind the big data specialist. The company made headlines on Wallstreet as it completed its long awaited IPO on September 30th. The stock price staggered at $10 throughout October after its debut on the NYSE. However, recent coverage from analysts… Read more
-
FeaturedDraftKing stock forecast for 2021 – analysts are bullish
DraftKing continues to impress Wallstreet after their ambitious call on 2021 revenue guidance. Here’s the 2021 forecast for DraftKing stock
-
FeaturedCronos stock forecast for 2021 – are the bulls right?
Cronos Group Inc (NASDAQ: CRON) stock has made a remarkable comeback in recent weeks. The companies stock price has gained 55% in the last month, reviving its bullish investor sentiment we initially saw in early 2019. The key drivers for this growth include the US election outcome, positive Q3 results and analysts optimistic outlook moving… Read more
-
FeaturedNovavax stock forecast for 2021 – is $200 realistic?
Novavax, Inc.(NASDAQ: NVAX) has seen an incredible year in stock price growth, increasing 1,1711.50% YTD. The companies COVID-19 vaccine saw the market rally behind NVAX, posting a 52 week high in August of $189.40. The company announced yesterday an agreement of principle with the Commonwealth of Australia for Acquisition of 40 million doses of NVX-CoV2373.… Read more
-
FeaturedWill Hyliion stock bounce back? Here’s what analysts are saying
Hyliion (NYSE: HYLN) stock has been on a downward trend losing 54.64% in value over the past month. The sell off incurred shortly after the SPAC merger was finalised on the 28th of September. Hyliion hasn’t been the only EV listed company who has seen short selling. WKHS and even Tesla have lost 33% and… Read more
-
FeaturedAnalysts are bullish on NIO stock – here’s what investors need to know
NIO (NYSE: NIO) has continued its bullish path throughout 2020, with the stock gaining an eye watering 2008.97% YTD. NIO’s bullish investor sentiment this year has outweighed majority of its smaller competitors. The “Tesla of China” is driving significant growth in the EV industry, particularly in the Asia Pacific region which has intrigued investors in… Read more
-
FeaturedSnap stock forecast 2021 – are the bulls too confident?
In a social media-driven world it should not shock you that the bulls are cheerleading a strong 2021 run for Snapchat. The contagious photography platform is expanding its customer base during the pandemic, which is pleasing to investors in terms of financial growth. While the bulls are telling a story of bodacious financial, customer, and… Read more
-
FeaturedLordstown Motors is surging – here’s the 2021 forecast
Lordstown Motors (NASDAQ:RIDE) ticker officially debuted on Wallstreet yesterday after the completion of its reversed merger with DiamondPeak Holdings (SPAC). The company received $675 million from the SPAC in funding to bolster their manufacturing and distribution of their EV Pickup truck model “Endurance”. Lordstown Motors gained national attention after President Trump had viewed the pick up truck… Read more
-
FeaturedIntel stock forecast – what does the future look like for investors?
Intel (NASDAQ: INTC) put on a show during the pandemic as they rode the technological wave. However, it seems the rapid growth might be slowing as analysts remain pessimistic for the short-term Intel stock forecast. The bulls are focusing on the bigger picture as financials look to rebound in 2024 and beyond. This article will… Read more
-
FeaturedWorkhorse stock falls to $20 – is now the time to capitalise?
Workhorse (NASDAQ:WKHS) took a 15% hit last week as the EV industry including Tesla struggled to gain any traction on Wallstreet. The stock corrected from its standing equilibrium at $23-24 to $19.20 with no associated news. Workhorse has since rebounded above the $20 mark however continues to experience unusually low volumes suggesting a large bounce… Read more
-
FeaturedPayPal stock forecast 2021 – how high can PYPL go?
To say PayPal (NASDAQ: PYPL) is on a rocket would be an understatement. The recent introduction of cryptocurrency and buy now pay later positions PayPal at the forefront of the payment revolution. Not to mention, the rise in online business is sending PayPal merchant fee revenue through the roof. However, the bears are shaking their… Read more
-
FeaturedSenmiao Technology (AIHS) forecast for 2021 and beyond
Senmiao Technology Ltd (NASDAQ:AIHS) is currently flying under Wallstreets radar. The stock has surged 213% over the past month, with investors continuing to rally behind the Chinese Fintech. With a current market capitalisation of $60.1 million, the micro-cap stock has captured speculators attention. Analysts are yet to place the first 12 month price target on… Read more
-
FeaturedFisker stock forecast 2021 – are the bulls outrageously optimistic?
Fisker is dividing wall street. On the one hand, the merger confirmation and promising prospects are making investors bullish. Contrast that to the bearish argument where investors see Fisker replicating Nikola’s downfall as opposed to Tesla’s meteoric rise. This article looks to breakdown the Fisker stock forecasts from both the bullish and bearish sides. Table… Read more
-
FeaturedWill INO stock bounce back? Here’s what you need to know
Inovio Pharmaceuticals Inc (NASDAQ:INO) has been on a recent downward trend, with the stock losing 56% of its value over the past three months. Currently priced at $11.85, INO rose to polularity amongst retail investors due to its sheer returns it produced between February and August of this year. The recent announcement on the 28th… Read more
-
FeaturedBank of America stock forecast 2021 – bullish or bearish?
Bank of America (NYSE: BAC), like most Banks, is laying the groundwork for a 2021 recovery. Buffett still stands firm by the company, but hedge funds are beginning to exit. Who is right? The future looks bleak for the coming months, but the long-term future is bright. (opinion not advice) This article looks to breakdown… Read more
-
FeaturedNIO stock news triggers 20% rally – will the bulls survive 2020?
NIO (NYSE: NIO) is emerging from the EV crowd and onto the podium as investors call the company “the Chinese Tesla”. The remainder of 2020 is packed with bullish catalysts. These include the unveiling of the EE7, Q3 earnings, month on month delivery updates, and continued talks about European expansion. Despite the positive NIO stock… Read more
-
FeaturedWill Workhorse land the USPS deal? – here’s everything you need to know.
Workhorse (NASDAQ:WKHS) investors are gearing up for an announcement from the United Stated Postal service (USPS) regarding their $6 Billion deal to revamp their delivery vehicles. WKHS surged 12.62% on Friday as Roth Capital analyst Craig Irwin noted that Workhorse was best fit for the USPS deal. Workhorse is the only contender for the deal offering… Read more
-
FeaturedHyliion merger sealed – 2021 forecasts and beyond
To say Hyliion (NYSE: HYLN) is a 2020 EV spectacle would be an understatement. What started as the hype behind the SPAC SHLL is mutating into EV truck fever for Hyliion. Mainly because SHLL/HYLN posted a monstrous 425% share price growth in three months. Bulls are now leading the charge in the Hyliion 2021 stock… Read more
-
FeaturedFastly stock forecast for 2025
Fastly’s (NASDAQ: FSLY) meteoric 2020 rise is making investors incredibly bullish for 2025. The American cloud service turned heads yesterday as the bulls drove a 13% rally in a day. However, optimism and extreme valuations can be a trap for some investors, especially in the technology industry. Thus, this article will provide an objective stance… Read more
-
FeaturedCharles Schwab stock forecast 2021 – TD Ameritrade merger and beyond
Charles Schwab stock (NYSE: SCHW) is all over the market headlines as they plan to finalise the Schwab-TD Ameritrade merger today. The acquisition is a strong chess play from the brokerage giant. However, an investment in the new company is not without risks, which the bears are making painstakingly clear. This article will look to… Read more
-
FeaturediBio’s stock forecast for 2021 and beyond
iBio inc. (NYSE:IBIO) rose to popularity amongst the investor community as they announced their intentions to develop a COVID-19 vaccine. The stock is currently trading 586% higher since the beginning of 2020. However since July, iBio stock has been on a downward slope which has since found a new equilibrium at $2. The initial announcement of… Read more
-
FeaturedAmerican Airlines stock predictions 2020 and beyond
American Airlines (NASDAQ: AAL) might be too big to fail, but are they too damaged to recover. Investors are banking on the pent-up passenger demand, stimulus packages, and government bailouts to trigger a long-term bullish recovery. However, nightmarish financials, the transition from corporate travel to internet communication, and record low passenger levels make a turnaround… Read more
-
FeaturedNikola stock forecast – are the JP Morgan bulls right or too optimistic?
Nikola Motors (NASDAQ: NKLA) is a volatility seesaw. Today’s positive press release saw Nikola bulls fling the bears into the air. However, alarming criticisms from Hindenburg research, sexual allegations against Trevor Milton, and a GM fallout could see the bears regain control of the seesaw. Thus, today’s article will look to break down and simplify… Read more
-
FeaturedAMD Q3 earnings forecast – are the bulls right?
AMD earnings are causing quite the bullish party on Wall Street. Significant growth in the PC, gaming, and cloud server business is the driving catalyst for the bullish forecast. Advanced Micro Devices (NASDAQ: AMD) releases Q3 earnings on the 27th of October. Options activity, analysts, and current financials all point towards expected or better than… Read more
-
FeaturedHere’s why analysts are bullish on Virgin Galactic stock
Virgin Galactic Holdings Inc (NYSE: SPCE) surged 24.8% on Monday as Ron Epstein, analyst at Bank of America announced a bullish $35 price target. This price target suggests an upside potential of 71% from todays current price. The bullish outlook from analysts gives long term shareholders of Virgin Galactic a vote of confidence moving into… Read more
-
FeaturedCruise line stock forecast 2021 – will CCL and NCLH recover ?
Carnival Crusie (NYSE: CCL) and Norweigan Cruise Line Holdings (NYSE: NCLH) are receiving a big push from the bulls. Management, institutions, more specifically Barclays, and analysts are all predicting an upswing in CCL and NCLH in 2021. However, the bullish cruise line stock forecast is receiving some criticism. Especially in the areas of the pent-up… Read more
-
FeaturedHere’s why Urban One (UONE) stock is up 90%
Urban One Inc (NASDAQ:UONE) has seen a volatile year of trading, with the stock reaching a 52 week high of $54.16 and a low of $0.95. The stock rose to popularity in the Robinhood community after UONE rose 2000% over a months period of trading. The media giant, founded by Cathy Hughes aims to tailor… Read more
-
FeaturedSRNE stock forecast indicates a bullish 2021 – is it real or COVID-19 hype?
Sorrento Therapeutics (NASDAQ: SRNE) was lacking direction as short-sellers brought down the stock after most positive announcements. However, the green light from the FDA allows the bulls to lay down the trackwork. The clear path is promising, but the volatility is making it difficult for investors to enter. Today’s article looks to make sense of… Read more
-
FeaturedSHLL closes in on merger date with Hyliion – here’s what you need to know
Tortoise Acquisition Group (NYSE: SHLL) has made a name for itself on Wallstreet this year as they plan to merge with EV truck innovator Hyliion. SHLL has surged 343% over the past quarter, as the merger date moves closer to finalisation. Over the past few days of trading, SHLL stock dipped sharply as the EV sector… Read more
-
FeaturedCVS stock forecast 2021 – will the healthcare giant bounce back?
CVS Health (NASDAQ: CVS) stock has been going on a rollercoaster ride in 2020 so far. The start of the year was promising as the healthcare giant hit 52-week highs. Unfortunately, COVID-19 sent CVS spiraling down. Investors are currently unsure what is in store for CVS come 2021 and beyond. Especially, as the CVS stock… Read more
-
FeaturedIs Peloton stock bullish for 2021?
The stellar run for home fitness in 2020 is making many investors ask is Peloton (NASDAQ: PTON) stock bullish for 2021? The virus elevated Peloton to one of the highest points in the online fitness arena. However, the slow transition back to regular gym life is forcing Peloton to adapt its business model. Will Peloton’s… Read more
-
FeaturedWill the Teva stock recover after a 10% sell-off?
Will Teva stock recover from the recent bloodbath? It is the big question institutions and retail investors are asking. On one end, investors believe the lawsuit and stagnating financials will cripple Teva. Conversely, the bullish hedge funds argue that Teva holds value in the long-term. Thus, today’s article will breakdown the recent sell-off, which institutions… Read more
-
FeaturedShorting the US market with SQQQ – here’s what you need to know.
ProShares UltraPro Short QQQ ETF (NASDAQ:SQQQ) is a leveraged (3x) ETF that inversely tracks the Nasdaq 100 index. The ETF gained serious popularity amongst investors during the market crash in March earlier this year. It is important to understand the instrumental purpose of certain ETF’s before looking to invest. The SQQQ is a highly risky… Read more
-
FeaturedInstitutions bought in before the $1 billion PIC XL Fleet merger – Here’s what you must know now
Pivotal Investment Corporation II (NYSE: PIC) shocked the investing world on Friday after announcing their merger with EV technology provider XL Fleet. Investors immediately bought shares in PIC to secure their position before the news spread. However, the question on everyone’s mind, is did Friday’s investors and hedge funds jump the gun? Thus, today’s article… Read more
-
FeaturedFDA gives Sorrento Therapeutics the green light to begin Phase I COVID-19 trials – Should you short?
Sorrento Therapeutics (NASDAQ: SRNE) is putting on a volatility show this week. The bulls were leading the charge at the start of the week but took a big rest on Wednesday, which saw SRNE pullback by 12%. All bullish hope seemed lost. However, today the FDA gave Sorrento the green light to begin phase I… Read more
-
FeaturedINO surges 10% pre-market – here’s what you need to know
Inovio (NASDAQ:INO) is set to open 10% higher this morning after the promising address by CEO & President Dr. Joseph Kim on the H.C Wainwright 22nd Annual Investment Conference. Dr. Kim advised that the initiation of Phase 2 trials for their COVID-19 vaccine INO-4800 is on track to commence later this month. The CEO also… Read more
-
Featured$4 billion IPOB Opendoor merger is set to revolutionise the real estate market
Social Capital Hedosophia Holdings Corp. II (NYSE: IPOB) stole a huge part of the spotlight after announcing a $4.8 billion SPAC with Opendoor. The digital real estate disruptor should make this one of the hottest SPACs of 2020. However, as the bulls rush in to snap up IPOB shares is shorting the SPAC a smart… Read more
-
FeaturedUnity Software IPO – Here’s what you need to know about the $1 billion tech company
Unity Software (NYSE: U) IPO is making noise on Wall Street ahead of Friday’s debut. Some investors are claiming Unity to be one of the hottest software IPOs of 2020. Especially as the valuation is a billion dollars. Today’s article will breakdown the IPO, Unity’s product offering, and everything investors must know before investing. … Read more
-
FeaturedCassava Sciences surges 148% on final phase 2 results
Cassava Sciences (NASDAQ:SAVA) held a conference this morning announcing promising Phase 2b trial results in treating patients with mild-moderate Alzheimer’s Disease. The company uses the drug Sumifilam to treat AD by reducing neurodegeneration and neuroinflammation. The results announced via conference call concluded that the data shows a promising increase in cognitive bio-markers within AD patients – an… Read more
-
FeaturedWhen will SPAQ become Fisker – here’s what you need to know
Spartan Energy Acquisition Corp (NYSE: SPAQ) is rallying up the bulls as we inch closer to the SPAQ Fisker merger. Investors are expecting to ride the bullish undertone in the lead up to the merger. However, below the surface, a SPAQ Fisker investment is exhibiting risks that investors must know. Thus, today’s article will explain… Read more
-
FeaturedNKLA stock forecast – who is right, the GM bulls or the Hindenburg bears?
Nikola’s (NASDAQ: NKLA) price action is mimicking that of a rollercoaster. The NKLA stock forecast 2021 is changing weekly, making it difficult for investors to understand the underlying sentiment. It seems NKLA’s volatility provides an El Dorado of riches to some investors. In contrast, others are left at the side of the road. Thus, today’s… Read more
-
FeaturedStarboard Value Acquisition Corp IPO – everything you need to know before investing
Starboard Value Acquisition Corp (NASDAQ: SVACU) is sliding onto NASDAQ this Friday, 11th September. Main Street does not focus on this SPAC as retail investors hone in on the trending blank check companies such as SHLL, SPAQ, and HCAC. However, some investors are contemplating a Starboard investment. Because if SVACU land an acquisition, then investing… Read more
-
FeaturedGeneral Electric stock 2021 forecast – have all the 2020 bears left yet?
General Electric’s stock (NYSE: GE) shapes up for a comeback as we enter 2021. However, claiming a 2021 bullish run is a bold claim. Because the GE stock is down 48% YTD. Nonetheless, today’s article will break down both sides of the 2021 argument for our readers and provide YIG’s take on a General Electric… Read more
-
FeaturedLululemon’s future post Q2 earnings – Does YIG see value in the fitness apparel giant?
Lululemon (NASDAQ: LULU), one of the world’s most-loved yoga-gear retailers, is bobbing and weaving the viruses punches as LULU is up 54% YTD. LULU’s earnings are tomorrow, which is causing the bears and bulls to divide. Some analysts adamantly believe LULU’s reputation will see the stock continue to rise into 2021. Whereas the bears are… Read more
-
FeaturedThe Apple bull is expected to steam into 2021 – Here’s what you need to know
Apple (NASDAQ: AAPL) is arguably the most talked-about and traded stock in the 2020 market. The Apple bull shrugged off the February and March bears and climbed 139% since the bottom. However, Apple’s meteoric rise is attracting a fair amount of pessimists leading into 2021. Especially as the economic carnage continues and speculations of a… Read more
-
FeaturedUVXY ETF captures investor interest – here’s everything you need to know
ProShares Ultra VIX Short-Term Futures (UVXY) is a listed ETF which provides investors leveraged exposure to the SP 500 VIX index. In short, the fund tracks the performance of the SP 500 VIX – a popular measure of the markets volatility. UVXY tends to increase in value when the market falls, as investors move to… Read more
-
Featured
NIO 2021 forecast – Does YIG see value in the EV dark horse?
NIO (NYSE: NIO) captivated the EV market in 2020. However, 2020 will soon become history as we enter 2021. Thus, NIO investors are itching to uncover whether the 2021 forecasts are bullish or bearish. Considering NIO is taking on the nickname the “Tesla of China”, we could assume that the projections are bullish. Nonetheless, YIG… Read more
-
FeaturedBrookline Capital’s $50 million IPO is bearish and bullish – here’s what you need to know.
Brookline Capital Acquisition Corp (NASDAQ: BCACU) is going public on Friday. However, with 2020 being an IPO frenzy, understanding which companies to investigate further is tough. Especially, as valuations leading up to IPOs can be deceptive. Today’s article will explain who Brookline Capital is to our readers and what you need to know before investing.… Read more
-
FeaturedITACU’s 2020 IPO hype is going unnoticed on main street – Does YIG see potential?
Industrial Tech Acquisitions Incorporated (NASDAQ: ITACU) is gaining momentum ahead of its IPO on the 9th September, yet it’s all quiet on the media front. Astronomical surges are now commonplace in the COVID-19 stockmarket, all because of volatility. However, retail investors often hear about the company after the unrealistic gains happen. Ultimately resulting in one… Read more
-
FeaturedHennessy Capital is riding the EV SPAC bull – does YIG see value beyond the merger?
Hennessy Capital LLC (NASDAQ: HCAC) is Wall Street’s rising SPAC star as they intend to merge with EV company Canoo. The merger will see yet another EV stock enter the market with uncontrollable momentum. Many investors seem to be getting in on HCAC in the lead up until the merger, all with the expectation of… Read more
-
FeaturedBiomerica set to release earnings this Friday – here’s what you need to know.
Biomerica (NASDAQ:BMRA) is set to release Q2 earnings this Friday, with experts forecasting an expected EPS of -$0.05. This would mark a 37% improvement for Q2 Earnings Year on Year. The medical diagnostic manufacturer has thrived on the opportunity this year to develop a viable COVID-19 test. Biomerica’s rapid COVID-19 test is marketed produce results… Read more
-
FeaturedZoom looks to post record earnings- Does YIG see value?
Zoom Video Communications (NASDAQ: ZM) is now the poster boy for working at home, socialising during the pandemic, and the bullish technology market. Zoom earnings are just around the corner, 31st August, which is causing share price expectations to polarise. While Wall Street expects Zoom to post another blowout earnings report, Zoom’s future remains unclear.… Read more
-
FeaturedApplied UV looks bullish ahead of Monday’s IPO – Does YIG see value?
Applied UV (NASDAQ: AUVI) is stepping onto the NASDAQ next Monday through a traditional IPO. However, the biotechnology company is receiving little to no coverage in the lead up to its big day. The absence of market commentary is not necessarily a bad sign as retail investors often hear about a company after the big… Read more
-
FeaturedFluidigm soars 25% on COVID-19 FDA approval – here’s what you need to know
Fluidigm Corporation (NASDAQ: FLDM) just became a bull-market magnet as its COVID-19 saliva kit received FDA approval. Optimism is high in pre-market trading as some bullish investors believe this is news to send FLDM soaring. However, the bears are screaming that a pump and dump is coming at the bell. The division in sentiment causes… Read more
-
FeaturedSalesforce surges 14% as investors rally behind better than expected earnings results
Salesforce (NYSE:CRM) crunched Q2 earning expectations posting an adjusted EPS of $1.44 in comparison to its expected EPS of $0.67. The software developer is set to open at $247.38 (14.5%) this morning according to pre-market. Salesforce is currently trading at all time highs, smashing its YTD stock value by 62.9%. It was recently announced the… Read more
-
FeaturedAfterpay and ZIP rally 20% before Thursday’s earnings – Does YIG see value?
Afterpay (ASX: APT) and Zip Co (ASX: Z1P) are putting on an impressive show before Thursday’s earnings with APT, and Z1P eyeing $100, and $10 respectively. The BNPL rockets seem to be poised for blast off come Thursday as institutions, main street, and analysts remain bullish. However, as the BNPL hill climbs higher, could a… Read more
-
FeaturedOKTA rallies 10% before earnings – Does YIG see value or hype?
Okta (NASDAQ: OKTA), a cloud software company for user identification, is causing optimism to erupt within investors ahead of this Thursday’s earnings. Considering all tech stocks are experiencing support from the raging bull, Okta’s bullish expectations should be no surprise. Today’s article will provide our readers with an objective breakdown of the earnings expectations and… Read more
-
FeaturedPlug Power continues its bullish path – here’s everything you need to know.
Plug Power (NASDAQ:PLUG) has made its name on Wallstreet, as investors continue to back the next generation hydrogen cell developer. The stock has surged 368.47% over the past six months, establishing very solid grounds for investor confidence. Plug Power develops hydrogen fuelled cells which power electric motors. The business aims to completely shift the power/transport… Read more
-
FeaturedGevo stock roars 230% on billion dollar renewable energy deal – Does YIG see value?
Gevo Incorporated (NASDAQ: GEVO) walked up the stock market podium to announce its largest renewable energy contract in history. The news instantly ignited a buying frenzy on Wall Street. Investors who missed Thursday’s boat are wondering whether the Friday boat will bring them a capital gain. However, investor optimism receives considerable criticism from the bears… Read more
-
Featured
SPAQ surges 30% as the hedge funds buy in before Fisker merger – Does YIG see value?
Spartan Energy Acquisition (NYSE: SPAQ), soon to be merging with Fisker, is the new EV kid on the block. While SPAQ is relatively fresh on the scene, its meteoric rise mirrors that of EV controversy Nikola Motors. However, the SPAQ momentum is starting to find a more sustainable equilibrium. Because after the Fisker merger announcement,… Read more
-
FeaturedJohnson & Johnson set to acquire Momenta Pharmaceuticals – here’s what investors need to know
Johnson & Johnson announced this morning that they have entered a “definitive agreement” to acquire Momenta Pharmaceuticals at $52.50 per share. The acquisition has been confirmed as an all-cash transaction, which has been approved “unanimously” by the Board of Directors from both J&J and Momenta. The acquisition is set to be finalised later this year,… Read more
-
FeaturedGenius Brands set to surge off Q2 earnings – here’s what you need to know
Genius Brands’ (NASDAQ: GNUS) Q2 earnings are generating significant noise on Wall Street. Some investors agree with the management and are proclaiming the results were impressive. At the same time, bearish investors are exposing the flaws in the financial reports, in particular dilution issues. The polarising entertainment company is down 80% in the past two… Read more
-
FeaturedAfter rising 50% on Friday is Mesoblast now a good investment ahead of COVID-19 trials?
Mesoblast (ASX: MSB) (NASDAQ: MESO) was on our portfolio since May. However, volume started to climb higher this week as an advisory committee voted in favour of Mesoblasts pediatric drug remestemcel-L (Rynocil). The positive catalyst triggered a Mesoblast buying party on the ASX and the NASDAQ. For now, investors are optimistic about Mesoblast’s medium-long term… Read more
-
FeaturedCureVac the newest vaccine contender on Wallstreet – here’s everything you need to know
CureVac’s (NASDAQ:CVAC) initial public offering in the US markets went incredibly well for investors, posting a 250% gain on its first day of trading. CureVac is a German Biopharma, based in Tübingen who specialises in the development of vaccines for infectious diseases. CVAC’s IPO raised $213.3 million USD in funding at its short price of… Read more
-
FeaturedSHLL jumps 15% as the smart money pours in – does YIG see value?
Tortoise Acquisition Group (NYSE: SHLL) first attracted the wallets of Wall Street when they announced their intention to acquire EV company Hyliion. The hype started to die down as the SHLL merger is still another month away. However, today Tortoise Acquisition surged 15% on what seems to be no news. Bullish investors hold their finger… Read more
-
FeaturedCisco falls on strong Q4 earnings – here’s everything you need to know
You might know Cisco Systems (NASDAQ: CISCO) as the alive dinosaur in the IT and network world. Cisco’s strong Q4 earnings reaffirm its king like status. However, their Q1 earnings guidance disappointed Wall Street. Some investors are confused as to whether or not to jump on the CSCO train. Because on the one hand you… Read more
-
FeaturedU.S government orders 100 million doses of Moderna’s vaccine, yet insiders are selling – here’s what you need to know
Moderna (NASDAQ: MRNA), alongside Novavax, is running at full speed in the vaccine race. The Trump Administration’s recent agreement with Moderna to order 100 million doses adds to the argument that MRNA is at the front of the pack. While the announcement is a positive catalyst, investors are doubtful that we will see an enormous… Read more
-
FeaturedTwilio rises 300% on cloud software hype – Does YIG see value?
Twilio (NYSE: TWLO) is the industry captain of cloud communications. A raging bull market and a digital economy drove the software company to unchartered territories. After the Twilio stock price rose, 300% investors were keen on buying shares. However, the recent 12% drop has made investors skeptical about whether a TWLO investment is worth it.… Read more
-
FeaturedINO falls 8% ahead of today’s earnings – does YIG see value?
Inovio Pharmaceuticals (NASDAQ: INO) is probably the most controversial COVID-19 play of 2020. Some investors are incredibly bullish on the vaccine frontrunner claiming the stock will be near Novavax very soon. However, many investors are pessimistic about INO, claiming it is a COVID-19 star fizzling out. Initially, the bulls seemed to be right as INO… Read more
-
FeaturedThe Teladoc Health Stock is up 200% – is it too late to get?
Medicine is changing, and the Teladoc Health stock (NASDAQ: TDOC) is at the cusp of the industry transformation. Teladoc Health allows users to access expert medical advice, organise medical records, manage health risks, and enter virtual mental health appointments at the touch of a button. Teladoc Health recently acquired biotech giant Livongo (NASDAQ: LVNGO). However,… Read more
-
FeaturedRobinhood traders lose 50% on Nikola Motors – Does YIG see value?
Nikola Motors’ (NASDAQ: NKLA) meteoric rise sucked in an enormous amount of Robinhood investors, professional investors, and criticism. Many investors are in no man’s land as the future direction of Nikola remains uncertain. Some investors are championing the shorting route, while others believe in that Nikola Motors is just suffering a setback. Thus, today’s article… Read more
-
FeaturedWorkhorse Group set to release earnings this week – here’s what you need to know.
Workhorse Group Inc (NASDAQ: WKHS) is set to release Q2 Earnings on Monday morning before market open. The US electric vehicle manufacturer operates in both the automotive and aviation industry. WKHS is most commonly known for it’s innovative spin on pick-up trucks and transport vans. Since July, WKHS has seen an enormous surge in investor… Read more
-
Featured54,000 Robinhood traders bought Rocket Companies on Friday – Does YIG see value ?
Mortgages are more than just a loan from a bank, they represent people’s hopes and dreams. Customers reward the businesses who satisfy the needs of mortgagors the best with truckloads of cash, which brings us to this week’s stock Rocket Companies (NYSE: RKT). Rocket companies is an online mortgage and car loan lender. The business… Read more
-
FeaturedBausch Health rises 25% on bad earnings – is this pump a trap for retail investors?
Bausch Health’s (NASDAQ: BHC) pre-market rally is causing the ears of investors to prick up as the word gets out. While the sentiment appears to be positive at the moment investors could be in for a rollercoaster at the bell. Considering the pre-market is a usually a façade for the trading day, many investors are… Read more
-
FeaturedSorrento Therapeutics soars 10% from Jim Cramer’s bullish outlook – should investors avoid shorting SRNE?
Sorento Therapeutics (NASDAQ: SRNE) is causing Wall Street to divide. Some bears are adamant that Sorrento will become a COVID-19 stock that will fade in a few months. Whereas the bulls are aggressively buying up SRNE shares as they believe the biotech has not even come close to its true value. While the overall war… Read more
-
FeaturedGoogle signs $450 million home security deal with ADT – here’s everything you need to know
Despite Google’s (NASDAQ: ALPHABET) monstrous size, they are always looking for new markets to tap into and dominate. Yesterday the tech giant grew its market foothold in the home security space after investing $450 million into ADT. ADT supplies secuity for residential and small businesses throughout America. The partnership triggered a buying frenzy on Wallstreet… Read more
-
FeaturedSeven Eleven buys out Marathon’s Speedway for $21 billion – does YIG see value?
Seven & I Holdings (TYO: 3382) took a bold move on Sunday by agreeing to buy out Speedway gas stations (NYSE: MPC). Despite the dollar tag, investors wonder whether buying up gas stations when the demand for oil is low was smart. Ultimately causing some apprehension as to whether investors should back Seven & I… Read more
-
FeaturedHere’s how much a $10,000 investment in this COVID-19 vaccine company is worth now
The COVID-19 vaccine industry has seen immense investor backing with popular US listed companies such as Moderna, Pfizer and Vaxart multiplying their pre-COVID value upwards of 500%-1,000%. However, Novavax, Inc. (NASDAQ: NVAX) has surpassed it’s rivals in stock value growth, currently priced at $143.10. An investment of $10,000 in NVAX after the initial COVID-19 vaccine… Read more
-
FeaturedSHL acquires Varian Medical Systems to create a gigantic US cancer company – here is everything you need to know.
Varian Medical Systems (NYSE: VAR) grabbed the stock market microphone to announce that it will be bought out by the German technology behemoth Siemens Healthineers. Some investors might view the transaction as one company swallowing another. However, the acquisition marks a quantum leap in the cancer fight. Considering cancer treatments are the crown jewels of… Read more
-
FeaturedLi Xiang jumps 40% on IPO – here is everything you need to know
Li Xang (NASDAQ: LI), an electric vehicle (EV) company, soared 40% on its market debut yesterday. At face value, an investment sounds excellent. Because all EV stocks are rising and it is one day after IPO, so bullish momentum should still be there. However, beneath the water lie sharks such as the ruthless competition of… Read more
-
FeaturedKandi Technologies climbs 200% on EV expansion into the US – Does YIG see value
The unrealistic gain train keeps on churning as Kandi Technologies (NASDAQ: KNDI) 200% rise is only a day after Kodak’s 300% surge. Kandi is a Chinese Electric Vehicle (EV) maker. Thus it should not be surprising that after their U.S. expansion announcement, we see retail and intuitional investors flock to the stock. Especially as EV… Read more
-
FeaturedKodak surges 300% on US government COVID-19 deal – does YIG see value in an investment?
Kodak (NYSE: KODK) was suffering from its multi-year downward trend as the iPhone made the Kodak camera look like a dinosaur. However, out of nowhere, the camera company launched itself back on the investing scene after securing a $765 million COVID-19 deal. Kodak will now play a critical role in producing key materials and chemicals… Read more
-
FeaturedTailored Brands heads for Bankruptcy – Does YIG see value in this Hertz like investment?
Tailored Brands (NYSE: TLRD) bankruptcy is the headline that is spreading wild. While it remains a claim, investors are wondering whether they should invest. Because most investors hear bankruptcy and think of the rental car company Hertz (NASDAQ: HTZ), which made some investors money. Like most insolvency cases there are always competing arguments over the… Read more
-
FeaturedIs Gold ETF GLD a smart investment during COVID – here’s what you need to know
SPDR Gold ETF (ARCX:GLD), like most gold investment vehicles, is gaining significant investor backing during these turbulent times. Economic expectations are changing daily with the virus. Ultimately leaving investors confused as to whether to play gold for the long term, short term, or even not at all. Table of contents 1. How does the Gold… Read more
-
FeaturedBNGO rises 100% off COVID-19 DNA research – here’s what you need to know.
Binano Genomics (NASDAQ: BNGO) catapulted itself onto the COVID-19 stage this week, which naturally saw investors flood the market. The area that BNGO is targeting is the COVID research field. However, for most investors, the scientific jargon can make the task of understanding the company, let alone investing, extremely difficult. Thus, this article will provide… Read more
-
FeaturedInvesting in Carnival and Royal Caribbean Cruise lines – Here’s everything you need to know.
Carnival Corp (NYSE: CCL) and Royal Caribbean Cruises (NYSE: RCL) have captivated investor interests as the cruise liners lost 70-75% value as COVID-19 grappled the cruise line industry. Both cruise liners have been on a gradual increase since the initial cliff-fall as speculators continue to buy the corporate giants at discount value. COVID-19 has seriously… Read more
-
FeaturedBoston Beer’s jump 25% on positive Q2 earnings – Does YIG see value?
Boston Beer (NYSE: SAM) set the beverage world alight on Thursday after it beat Wall Street’s Q2 earnings estimate. A beer company exploding during a pandemic might sound unusual. However, the growing light beer industry, and the high demand for alcohol during tough times would say otherwise. The quietness on the vaccine front and the… Read more
-
FeaturedDraftkings rise 20% off new online casino app – does YIG see value in an investment?
Draftkings (NASDAQ: DKNG) is making a name for itself in the betting and investment world. While most stocks are falling off a cliff during the pandemic Draftkings continues to grow with little interruption. Mainly because of their market foothold in the growing online gambling space (sports, casino, and e-sports). However, with the NASDAQ steaming full… Read more
-
FeaturedU.S. Health officials order 100 million doses of Pfizer’s vaccine – does YIG see value?
Along with the NASDAQ, vaccine stocks have wrenched back the stock market remote control as the pandemic worsens. Today, it was Pfizer (NYSE: PFE) who stole the spotlight. U.S health officials have agreed to pay $1.95 billion for 100 million doses of Pfizer and BioNTech coronavirus vaccine. The news is causing the bulls to charge… Read more
-
FeaturedNorthern Dynasty soars 35% on this Friday’s pebble mine decision – here is what you need to know.
Northern Dynasty Minerals (NYSE: NAK) appears to be the mining small-cap gift that keeps on giving, after rising 15% this week. NAK is a Canadian mining company that explores mineral properties in pebbles, gold, copper, and many more within the United States and Canada. The recent surge is causing the bulls to rally behind Northern… Read more
-
FeaturedActinium Pharmaceuticals hits 150% gain over 2 months – here’s everything you need to know
Actinium Pharmaceuticals (NYSE:ATNM) has caught the attention of investors as the stock continues its path of strong bullish momentum. ATNM is likely to open at $0.56 according to pre-market movements, marking a 211% gain over the past 2 months. The Bio-Pharma works on the development of commercial therapies for bone marrow transplant and other adoptive cell… Read more
-
FeaturedAstra Zeneca posts positive Phase I COVID-19 trial data yet investors sell – does YIG see potential?
Astra Zeneca (NYSE: AZN) had investors on the edge of their seats this morning in anticipation of COVID-19 data. AZN put investors at ease after their COVID-19 Phase I trial saw a positive immune response in patients. Most investors expected the stock to rocket off such news. However, investors instantly began to sell after the… Read more
-
Featured
Eldorado Resorts and Caesars Entertainment are merging this week – here is everything you need to know
The $17 billion merger between Eldorado Resorts (NASDAQ: ERI) and Caesars (NASDAQ: CZR) will produce the world’s largest casino company. Many investors were not giving these companies much thought as the merger still needed the regulatory green lights. However, Eldorado Resorts received the ‘final yes’ from New Jersey regulators on Friday. The merger is now… Read more
-
Featured
TNXP set to fill an unmet COVID-19 need – here is everything you need to know.
Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant investor backing after releasing a COVID-19 announcement. TNXP stock price instantly surged. It’s no secret, COVID-19 press releases are the wallet magnets of the stock market. However, the share price movement of Tonix is unique. Mainly because TNXP did not gap up by an astronomical amount. Leaving many… Read more
-
FeaturedGENE jumps 120% off COVID-19 risk test then enters a trading halt – Does YIG see potential?
Most investors have probably never heard of Genetic Technologies (NASDAQ: GENE) before the coronavirus. However, ever since they announced a possible COVID-19 risk test, investors could not get enough. That is until today’s trading halt prevented people from investing. The COVID-19 pump and dump theory is becoming painstakingly common as the virus rages on. A… Read more
-
FeaturedModerna COVID-19 vaccine success – here’s everything you need to know.
Moderna (NASDAQ:MRNA) alongside the US National Institutes of Health have made a historic breakthrough in the race for a viable COVID-19 vaccine. MRNA’s results showed all 45 patients from the Phase 1 trial saw an induced anti-body production. This anti-body production simply put helps bolster the individuals immune response to the virus. The markets are expected… Read more
-
FeaturedJRJC surges 170% off Dow Jones partnership – here is everything you need to know.
It is not every day that a Chinese financial services company links arms with the global news business Dow Jones. So it should come as no surprise that as China Finance Online (NASDAQ: JRJC) secures a partnership with Dow Jones, the bulls instantly rally behind. JRJC is already up 170% in pre-market trading. The rise… Read more
-
FeaturedVaxart is up 60% on vaccine speculation – does YIG see potential?
Vaxart (NASDAQ:VXRT), like most COVID-19 stocks, is receiving a re-injection of investor confidence as the virus rages on. However, Vaxart is fairly new to the COVID-19 race, as they have not started any human trials yet. Some investors are straying away from Vaxart because of their late arrival and unlikelihood of creating a viable vaccine… Read more
-
FeaturedWall Street expects Netflix to post positive earnings on Thursday – does YIG see potential?
Netflix (NASDAQ: NFLX) is mutating into a NASDAQ giant as the pandemic sends thousands of viewers towards the streaming service. The massive influx of users is causing investors and institutions to forecast positive FY2020 earnings on the 16th of July. It seems that Netflix is apart of the lucky few who could be reporting positive… Read more
-
FeaturedJ.P Morgan set to release earnings on Tuesday – here’s everything you need to know
JP Morgan Chase & Co (NYSE: JPM) alongside other corporate giants will face the music this week as they are set to release second-quarter earnings for 2020. The timing of the JP Morgan earnings report will be on Tuesday, July 14, 2020. While the investor conference call will commence at 8:30 a.m. (Eastern US). Expectations for… Read more
-
FeaturedWayfair tumbles 3% on human trafficking conspiracy – does YIG see value or a bearish future?
Wayfair (NYSE: W) is not the first thing that comes to mind when you think of human trafficking. Thus, when a Wayfair child trafficking conspiracy arises, it turns the online business and investment world on its head. Conspiracy stories often contain competing narratives that cause investors to become confused as to what to believe. The… Read more
-
FeaturedSPAQ surges 50% off potential Fisker merger – here is everything you need to know.
Spartan Energy Acquisition (NYSE: SPAQ) is rising on the possibility of acquiring EV maker Fisker. Initially, investors might think most EV companies are worth the investment. Especially, as Nikola, NIO, and Hyliion-SHLL provided some nice capital gains over the past few weeks. However, some investors today are trading off the EV hype instead of the… Read more
-
FeaturedAfterpay hits a new all-time high – could they reach $100?
Afterpay (ASX:APT) stunned the entire market after hitting a new all-time high of $75, resulting in a 725% rise in three months. APT’s recovery from COVID-19 instantly caught the eyes of many investors. However, doubt crept in that Afterpay’s growth mimicked that of a bubble. The entire BNPL is surging like a missile. Making many… Read more
-
FeaturedNVAX receives $1.6 billion from Trump’s Operation Warp Speed, causing Novavax to cross $100 – should you invest?
Novavax (NASDAQ: NVAX) inched closer to the COVID-19 vaccine finish line after receiving $1.6 billion in government funding today. The bulls are now rally in large numbers behind the COVID-19 biotech. Especially in light of today’s announcement. However, many investors wonder how long it will be until the NVAX bulls have to rest? Because if… Read more
-
FeaturedBREAKING: Genius Brands land its “once in a lifetime asset deal – Stan Lee Universe”
LIVE: Follow the Genius Brands public announcement here.
-
FeaturedCredit Suisse set to delist UGAZ and DGAZ on the 12th of July- here is everything you need to know.
Credit Suisse, back on the 22nd June, decided to delist several leveraged ETNs. In particular, the delisting of Velocity Shares 3x Long Natural Gas ETN (UGAZ) and UGAZ’s inverse VelocityShares 3x Inverse Natural Gas ETN (DGAZ) is gaining traction. Does an Exchange Trade Note sound foreign to you? If so, we provide our viewers with… Read more
-
Featured
NIO soars 16% after their Q2 sales beat analysts expectations – is it too late to invest?
NIO incorporated (NASDAQ: NIO), is spreading EV fever at lightning speed after it posted better than expected sales results. However, it is not just NIO that is hot of the EV investment radar. The Tesla (NASDAQ: TSLA), Workhorse (NASDAQ: WKHS), and Hyllion (NYSE: HYLN) bulls are all charging together, providing plenty of opportunities for investors.… Read more
-
FeaturedNXTD jumps 75% on revolutionary notification device for the elderly – should you invest?
Nxt-ID (NASDAQ: NXTD) skyrocketed in pre-market trading after it announced the commencement of testing for its WIFI notification device. Society is continuously striving to improve seniors’ indpendence, especially as our ageing population is growing at an unprecedented rate. Independency for seniors could include medical, physical, or financial independence. Thus, it should not surprise us that… Read more
-
FeaturedINO falls 18% on positive phase I COVID-19 trials – where to next for investors?
Inovio Pharmaceuticals (NASDAQ: INO), last week’s COVID-19 spectacle has now capitulated investors into no mans land after falling after positive Phase I data. It seems strange right, investors were backing INO with the expectation of positive phase I trials. INO fulfilled the expectation yet the bears decided to take the biotech to the woodshed. The… Read more
-
FeaturedMU’s revenue rises 16% off the digital economy – is Micron Technologies a good investment?
Micron Technology (NASDAQ: MU) is rising in pre-market trading after posting impressive financials for Q3 of 2020. In the current market, where greed and fear are on steroids, it is refreshing to see a stock rise because of a fundamental improvement in the company. However, an increase in financials is just a small part of… Read more
-
FeaturedVaxart rises 300% after its COVID-19 vaccine joins Trump’s Operation Warp Speed – is now the time to invest?
Vaxart Incorporated (NASDAQ: VXRT), wrenched the spotlight off COVID-19 frontrunners after its oral vaccine received funding from “Operation Warp Speed,” Trump’s accelerated vaccine program. The funding is causing investors to empty their wallets into the stock. The stock did skyrocket to the moon initially. However, now VXRT is following a downward spiral. Investors just becoming… Read more
-
FeaturedAfter landing a 10-year deal with Gap, Kayne West sends GPS soaring on new Yeezy Gap line.
When you think of Gap (NYSE: GPS) the words luxury, status, and fashion-edge clothing probably do not come to mind. However, the retail perception of Gap could radically change after they announced a partnership with Kayne West. Investors and clothing enthusiasts are extremely excited about the partnership. However for those sitting on the fence or… Read more
-
Featured
SHLL surges 60% off EV merger announcement – could you profit off shorting the speculation?
Tortoise Acquisition Corp (NYSE: SHLL) is acting like a magnet to robinhood investors as the stock surged 60% in a few days. The imminent merger between Hyliion incorporated and SHLL caused the volcanic eruption on wall street. While the merger sounds promising, some investors question the validity of the bullish move. Leaving many investors at… Read more
-
FeaturedESKO skyrockets 170% after FDA approves its brain injury device – is Esko Bionics worth the investment?
Esko bionics (NASDAQ: ESKO) is causing the eyes of investors light up with money symbols after the FDA gave the green light yesterday. While volatility is high, the future is showing signs of upward growth. However, the bears could ignite a sell-off at any point. Making many investors wonder, is Esko Bionics a good investment?… Read more
-
FeaturedSRNE surges 20% off COVID-19 lawsuit – has news been leaked?
Sorrento Therapeutics’ (NASDAQ: SRNE) saying they have a COVID-19 treatment that offers a 100% protection, before conducting trials, was an incredibly bold statement. SRNE’s optimistic announcement not only lit the investment world alight but also pushed them into the legal spotlight. It is the possible lawsuit charges that caused the bears to multiply. However, SRNE… Read more
-
FeaturedPlug Power set to surge as investors back a next generation hydrogen fuelled economy
Plug Power Inc. (NASDAQ:PLUG) is set surge for the second day in a row, as investors rally behind the largest hydrogen cell manufacturer of its kind. PLUG announced it has completed its acquisitions of United Hydrogen and Giner ELX.
-
FeaturedINO’s COVID-19 vaccine receives $71 million in government funding – how high can the INO stock go?
The COVID-19 vaccine market was fading as economies began to recover. However, the insurgence of new coronavirus cases and deaths is causing investors to gravitate towards COVID-19 vaccine frontrunners Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and Inovio Pharmaceuticals (NASDAQ: INO). It makes logical sense that investors rally behind the vaccine companies. Especially as they have… Read more
-
FeaturedWhy is the Workhorse stock up 50% – will they surge like Nikola?
First, it was Nikola (NASDAQ: NKLA), then INO (NASDAQ: INO), and now it is the Workhouse stock (NASDAQ: WKHS) that is exploding. It seems the electric vehicle spider web is starting to slowly reveal a clearer picture of who are the prominent businesses besides Tesla (NASDAQ:TSLA). After rising 50% in a week investors wonder whether… Read more
-
FeaturedWhat TVIX investors need to know before Credit Suisse delists the ETN on July 12th
Credit Suisse announced it’s intention to delist the popular Exchange Traded Note VelocityShares Daily 2x VIX (TVIX) linked to the S&P 500 VIX Short-Term Futures. Alongside 8 other publicly listed ETN’s, TVIX will no longer be traded on the NASDAQ effective of July 12th while issuances suspended on the 3rd of July.
-
FeaturedVirgin Galactic soars 16% on space deal with NASA – is now the time to invest?
Virgin Galactic (NYSE: SPCE) is experiencing investor backing after they signed a spaceflight program with NASA today. At large, Space X probably comes to mind first as opposed to Virgin Galactic. However, SPCE’s recent developments in hypersonic flights and today’s NASA deal paint a different market picture. One in which Virgin Galactic and Space X… Read more
-
FeaturedBREAKING: Glenmark’s COVID-19 drug gets market approval – causing an enormous rally in India today.
Glenmark Pharmaceuticals (XNSE: GLENMARK) COVID-19 drug, FabiFlu, is acting as a magnet to the eyes and wallets of investors. Considering India has 426,910 coronavirus cases and counting, it makes sense that many eyeballs are watching the Mumbai based biotech. Indian COVID-19 cases are forecasted to grow before they flatten. Thus, many investors are scratching their… Read more
-
FeaturedMarket Update: The bulls & bears are locked in a titanic battle – who will emerge victorious?
Written by Sergeo Domtchenko Trying to make sense of all the movements this week has left many investors with a migraine. Bouncing around between significant gains & losses, the ASX 200 gathered momentum to finish the week 1.6% higher at 5942.6 points. This marks a 30.7% increase from the market lows that we experienced on March… Read more
-
FeaturedBlack Lives Matter rally sees BYFC skyrocket 300% – is this another UONE?
Broadway Financial Corporation (NASDAQ: BYFC) is up over 300% from what seems to be an enormous Black Lives Matter rally. Google (NASDAQ: GOOGL), Facebook (NASDAQ: FB), Netflix (NASDAQ: NFLX), Twitter (NASDAQ: TW), Apple (NASDAQ: AAPL), and Amazon (NASDAQ: AMZN) injected a combined total of $1.1billion into black-run businesses. Hence why every investor under the sun… Read more
-
FeaturedSupermarket giant ‘Albertsons’ set to IPO next week – should Walmart investors be worried?
Written by Sergeo Domtchenko When you think of the retail industry, who comes to mind first, it is probably not Albertsons? The likes of Walmart (NYSE: WMT), Woolworths (ASX: WOW), Wesfarmers (ASX: WES), and the Super Retail Group (ASX: SUL) instantly come to mind for most investors. Last year alone, the U.S. retail industry was… Read more
-
FeaturedENPH stock jumps 16% on fraud allegations – should you short or take a long-term approach?
Enphase Energy (NASDAQ: ENPH) rises on fraud allegations. Sounds strange, right? The promising energy stock is turning heads in the investment world. Because their impressive 9540% share price growth could be entirely based on fabricated revenue figures. So let’s get to the bottom of this investment dilemma. Table of contents 1. Why is ENPH up? 2.… Read more
-
FeaturedWhy did Split It payments rise over 100% today – should you ride the wave or short?
Why did Split It payments rise over 100% today – should you ride the wave or short?
-
FeaturedWhy has UONE soared over 2000% in the past week?
Urban one’s (NASDAQ: UONE) stock rise is attracting investors from all trading platforms. After exploding 2000% many investors are eager to find out why the bulls owned the chart? Because if there is room to grow in Urban one then investors could potentially profit off unrealistic trading activity. Table of contents 1. Why is Urban… Read more
-
FeaturedThese US stocks are set to surge this morning as the Dow set to open 800 points higher
The Dow Jones Futures Index predicts a 800 point rally this morning as investors find confidence in the recent sales data released today. We have seen a wild turn of events over the past week, with Dow futures swinging from intense highs to even greater lows. This extreme volatility is concerning, however at this point… Read more
-
FeaturedVanguard ETFs VTI and VOO look to surge as investors shrug off last week’s losses.
The market is a rollercoaster. However, who is controlling the monstrous ride? Is it mum and dad investors, fund managers, COVID-19 vaccine frontrunners, or the government? No single group is controlling the market. Instead, fear and greed have the remote control over the market. Greed controlled the rollercoaster for the past month as a false… Read more
-
FeaturedStarbucks suffers a $3.2 billion loss – can the coffee giant recover?
COVID-19 is disrupting the retail industry. Retailers are closing stores, laying off employees, and radically restructuring their business models to suit the digital economy. Starbuck’s (NASDAQ: SBUX) slump in growth during the pandemic gives investors an insight into the suffering retail industry. Starbucks has fought hard to make coffee and SBUX inextricable. The question on… Read more
-
FeaturedPalantir Technologies 2020 IPO could be massive – does Amazon need to look in its rear view mirror?
‘Big Data & Machine Learning’ is an exciting, emerging field. It promises to change our lives radically. More data has been created in the last two years than the entire history of humankind. For the standard Fortune 1000 company, just a 10% increase in data accessibility has resulted in an average revenue gain of U.S.… Read more
-
FeaturedTVIX made 2000% in a month – is June round 2?
The sudden surge in the TVIX would suggest the bulls are falling off a cliff edge. While the future direction of the stock market is still in limbo land, negative US futures have set the tone for the week. The Dow, S&P 500, and NASDAQ futures are down 485, 50.5, and 124 points respectively (at… Read more
-
FeaturedTesla crosses $1000 – is it too late to invest ?
The bears are taking the indexes to the woodshed. Their claws are now entrenched in the markets, and we should see the losses return (opinion not advice). However, it seems the tech-heavy NASDAQ is immune to the pandemic and the sharp claws of the grizzlies. You do not have to look any further than Tesla’s… Read more
-
FeaturedNikola causes NIO to climb 100% – Is the Chinese EV stock now a raging bull?
The Electric Vehicle space is like a spider web. Endless EV companies are competing but also planning possible acquisitions and M&A. Thus it can be hard to navigate the spider web or even choose a potential winner. However, as time progresses, the future industry captains emerge. In is safe too say Tesla (NASDAQ: TSLA) is… Read more
-
FeaturedHertz jump 500% off bankruptcy – should you short or invest now?
Management turmoil, risky leverage, and signing acquisitions that could only be sustained with record revenue is a scary picture right? Hertz Global Holdings (NYSE: HTZ) were living through this nightmare for the past few years. However, the car company plummeted when the COVID-19 storm emerged. Creditors were frustrated with the risky leverage, disappointed with insignificant… Read more
-
FeaturedCHK surges 200% but look to file for bankruptcy – here’s what you need to know.
Why did Chesapeake Energy soar by 200%? Chesapeake Energy Corporation (NYSE: CHK) plummeted because of the nightmarish oil scenario. However, the recent turnaround in the future outlook for oil is causing the Energy Giant to skyrocket. Especially, as OPEC + Russia agree to extend to historic oil cuts to July in an attempt to stabilise… Read more
-
FeaturedEnochian Biosciences Skyrockets 240% pre-market on potential HIV cure
Enochian Biosciences (NASDAQ:ENOB) stock price has set for the stars this morning – with pre markets predicting the stock to open 240% higher. The significant increase has come off the back of a press release confirming an FDA meeting which successfully “aligned” with Enochian’s strategy for a HIV cure. This news although a first of… Read more
-
FeaturedRussia and OPEC extend historic oil cuts – are oil stocks in limbo land?
The demand for oil is at a nightmarish level. The lack of travel, the signifcant omission of cars in a stay at home economy, and the Russia-Saudia Arabia oil war are causing the oil crisis. The first two problems stem from COVID-19, which should dissipate. However, Russia- Saudi Arabi, and OPEC hold the future direction… Read more
-
FeaturedWill Webjet and Flight Centre make your portfolio jet off?
With restrictions lifting and international travel on the horizon, Australians eager for a holiday will soon be flocking to the nearest travel agent in hopes of planning the next family vacation. Today we will look at two of the ASX’s most traded travel agents Webjet Limited (ASX: WEB) and Flight Centre Travel Group (ASX: FLT).… Read more
-
FeaturedAmerican Airlines are soaring through the air on a 40% gain – how long will it last?
It feels like only yesterday that travel stocks were crashing. Warren Buffett sold off his airline stocks, and the entire consumer sentiment was down. In retrospect, it seemed logical that Airlines were down because the outlook for the travel industry was grim. However, our appetite for travel is rising. So much so that American Airlines… Read more
-
FeaturedGenius stock price has grown 2634% since January – here’s what you need to know
Genius Brands International Inc (NASDAQ:GNUS) has skyrocketed since the beginning of 2020 as the company just keeps on giving to Bullish investors. With a tidy market cap of $763m the companys simple game plan has proved an effective business model for exponential growth. The company creates multi-media animations and licenses them to retail channels and… Read more
-
Featured
Zip is up 450% – is it too late to invest?
Investors always viewed Zip Co (ASX: Z1P) as the little brother to Afterpay. However, the investor sentiment is beginning to change as Z1P is up an impressive 70% for the week. Almost every investor is jumping on the Z1P train. However, many investors standing at the station are wondering whether there is time to invest… Read more
-
FeaturedZoom’s earnings are today – should you short or invest for the long-term?
Zoom Video Communications (NASDAQ: ZM). Zoom, is now synonymous with video calling. However, Zoom was not always flying high. It feels like the world blinked, and then Zoom became a household name. While we all bunkered down, customers and investors began flocking to Zoom in record numbers. COVID-19 ultimately triggered a 200% surge in ZM… Read more
-
FeaturedGilead produces mixed COVID-19 trial results – investors now look to Mesoblast.
Biotechs universally share one mission. The industry aims to prevent or cure diseases to sustain a higher life expectancy. If a biotech successfully achieves its mission, humankind, the patients suffering, and investors all experience euphoria. However, if a biotech fails to develop a viable drug then the nightmarish scenario of people suffering continues. It seems… Read more
-
FeaturedDeutsche Bank raises their target price on TGT to $131 – is now the time to invest?
Is NYSE: TGT a target for your portfolio? First Coronavirus and now civil unrest is playing its toll on American businesses. The protests over a police officer killing George Floyd is causing business owners to shut up shop. Target Corp. (NYSE: TGT) announced yesterday that 170 stores across the United States closed because of looting… Read more
-
FeaturedADAP soars 150% on positive Phase 1 cancer trials – is a sell-off inevitable?
Why did the ADAP surge this week? Adaptimmune Therapeutics PLC (Nasdaq: ADAP) skyrocketed 128% on Friday. Investors rallied behind ADAP because of their positive phase 1 cancer trial. ADAP’s synovial sarcoma cancer candidate (ADP-A2M4) reported a 50% response rate in patients suffering from lung, head, and neck cancers. The phase 1 trial confirmed the safeness,… Read more
-
FeaturedSNOA explodes 150% after the ARTG approves their COVID-19 sanitiser
Biotechs are having a field day on Wall Street as every day, a new 100% gain is coming across our desks. The unrealistic gains highlight just how unique the current bear market is. Mainly because a worldwide pandemic is not the typical root cause of financial crises. From the oil recession in 1973 to extreme… Read more
-
FeaturedGreenpro surges 600% after acquiring 4% in the Millenium Sapphire – is the future bullish?
Written by Sergeo Domtchenko To say that the financial sector is going through a “rough patch” is an understatement. Profit plunges, dividend cuts, frozen loan repayments, and suspended executive pay increases have been the fallout of the COVID-19 pandemic. Since the market highs recorded on February 20, the S&P 500 Financial Index fell by over… Read more
-
FeaturedABIO skyrockets 225% today on COVID-19 treatment – have all the gains been made?
An important lesson to understand in investing is that buyers invest in what they believe to be true even if it is false. Biotechs popping up every second and developing a possible COVID-19 treatment is a perfect example. Many investors buy into the biotech on the belief that the company could develop a viable treatment.… Read more
-
FeaturedMersana Therapeutics reports positive cancer drug results – causing uncontrolled buying.
A cure for cancer is the most desirable statement for scientists and investors alike. However, optimism is often met with disappointment as the task of curing cancer is no easy feat. Despite the difficulty, the scientific world continues to develop drug after drug in an attempt to eradicate the horrific group of diseases. Despite a… Read more
-
FeaturedHere’s the latest on the German DAX and the opportunities that are arising for investors.
The DAX is an index made up of some of the largest companies within Germany listed on the Frankfurt Stock Exchange. The companies listed on the DAX must meet specific criteria – a testament to the high quality these companies display. The DAX data over a period of 42 years – is relatively linear (inc.… Read more
-
FeaturedNovavax’s COVID-19 vaccine enters Phase 1 trials – is Moderna in trouble?
A vaccine is an unlikely solution. However, biotechs often tirelessly work on vaccines even after the expiration date of a virus. For example, vaccines for ebola, Zika, and Sars2 are still in development. Thus if a vaccine is unattainable before COVID-19 fizzles out, biotechs will continue to create a vaccine. Because we do not want… Read more
-
FeaturedCanopy growth soars 53% – is now the time to go pot stock shopping?
The entire cannabis industry is on fire. It might seem weird to see bullish cannabis activity during COVID-19. However, the virus caused the marijuana market to plummet back in February and March. In turn, investors saw unbelievably low prices and went pot stock shopping. The initial recovery of the industry is understandable, considering the main… Read more
-
FeaturedEvofem skyrockets after the FDA approves its birth control gel.
Why did the stock rise? Evofem made headlines after the FDA approved Evofem’s (NASDAQ: EVFM) new birth control gel “Phexxi.” Phexxi is an applicator that women insert before sex to prevent pregnancy. The FDA approved the drug through Phase 3 clinical trial, enrolling tests of 1,330 women. Evofem achieved an efficacy rate of 86.3%, which… Read more
-
Featured
Market Update: US – China tensions escalate – is this bull market a sucker’s rally?
Despite the false bull market the Australian markets failed to maintain their positive momentum throughout the week. The ASX 200 slipped on Friday to close out the week 0.96% lower at 5497 points. However, this was not enough to erase the gains that were made by Moderna’s positive vaccine results However, this week saw renewed… Read more
-
FeaturedChinese company shows early signs of promising COVID-19 vaccine.
The vaccine race involves many runners, with the leaders being Moderna (NASDAQ: MRNA), Inovio (NASDAQ: INO), and Novavax (NASDAQ: NVAX). It feels like many vaccine companies are sprinting as they accelerate through the clinical timeline. However, the US government raised the stakes on Thursday when they announced a $1.2 billion injection into AstraZene’s untried vaccine.… Read more
-
FeaturedHow you could profit off shopping centres reopening?
To most Australians, shopping centres exist for one reason, to make you poorer. Ever since the introduction of the credit card in 1951 and more recently, Buy Now Pay Later, shopping centres have become a national sport. However, for the sharp investor, shopping centres can make a great addition to your portfolio. In today’s article,… Read more
-
Featured
IBM announces company-wide layoffs – are they still worth the investment?
Written by Sergeo Domtchenko The technology sector continues to take a pounding from the Coronavirus. The demand for enterprise IT products is in free fall. Look no further than the International Business Machines Corporation (NYSE: IBM). Today we will discuss why IBM made headlines this week and discuss whether it is worth the investment at… Read more
-
Featured
Potential FDA approval sees Seneca surge 100+%
Seneca Biopharma (NASDAQ: SNCA) came out of the markets storming 100% higher today at $1.67. The volcanic surge is off the back on no news, leaving investors confused. SNCA forums on Yahoo Finance and Stockwits are flooded with the same question “why is SNCA up”? Why is Seneca surging? The unsureness of why SNCA is… Read more
-
FeaturedUS-China trade war escalations could create another bear market.
Before COVID-19, the tensions between the US and China were rising. The two economic powerhouses are already fighting over the origins of the virus, a trade war would see the relationship sink further. Many experts say that China and the US are in a “new type of cold war”. Especially as the level of trust… Read more
-
FeaturedNano Dimension surges 400% off 3D printing breakthrough.
3D printing is tomorrow’s technological future. The technology is new and creates an itch in the minds of investors, consumers, and the government. The new wave of 3D printers can fabricate anything from keyboards to human body parts. It seems the possible creations are limitless. Making it fair to say that 3D printing is and… Read more
-
FeaturedNovavax look to repeat last week’s 120% gain.
Novavax (NASDAQ:NVAX) look to surge come market open with pre-market up 13% (at the time of writing). Novavax captured the wallets of investors last week when they received $384 million in vaccine funding from CEPI. This week NVAX is expected to captivate investors with a new all-time-high. Which seems achievable, especially if last week’s insane… Read more
-
FeaturedModerna set to surge after producing positive trial results for COVID-19 vaccine
Moderna announced this morning that their interim Phase 1 data for COVID-19 vaccine has shown positive results. The company has been heavily watched by investors and speculators alike – as their vaccine (mRNA-1273) continues to show positive signs. The announcement confirmed the Biomedical Advanced Research and Development Authority (BARDA) are in support of the companies phase…
